Global Home Infusion Therapy Market Overview
The Global Home Infusion Therapy Market size is expected to grow from USD 22.98 billion in 2023 to USD 40.92 billion by 2032, at a CAGR of 6.62% during the forecast period (2024-2032).
Home infusion therapy is a rapidly growing segment within the healthcare industry, providing patients with the convenience and comfort of receiving intravenous medications or fluids in their own homes rather than in a hospital or clinic setting. This form of treatment is typically used for patients requiring long-term care for conditions such as infections, immune deficiencies, dehydration, chemotherapy, and pain management. The therapy involves skilled healthcare professionals administering medications through various infusion methods, ensuring patients receive proper dosage and monitoring.
The industry has seen significant expansion due to several factors. Firstly, an aging population with complex medical needs prefers home-based care for its comfort and reduced risk of hospital-acquired infections. Secondly, advancements in medical technology and infusion devices have made it easier and safer to administer treatments outside of traditional healthcare settings. Moreover, healthcare policies and reimbursement structures increasingly favor home infusion therapy as a cost-effective alternative to hospital stays, promoting its adoption among healthcare providers and insurers.
Key stakeholders in the home infusion therapy industry include specialized pharmacies, home healthcare providers, infusion nurses, and medical equipment suppliers. These entities collaborate closely to ensure seamless delivery of care, from prescribing medications to monitoring patient outcomes. Regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS) and accreditation organizations set standards to ensure quality and safety in home infusion services, further driving the professionalism and reliability of providers in the industry.
Market Dynamics and Key Factors of Home Infusion Therapy:
Drivers:
Hospital-Like Care at Home
Patients can receive an innovative and comprehensive set of services with a variety of care alternatives when they choose home infusion services. Home services can help patients to avoid extended hospital stays and high medical fees by providing care in the comfort of the home. Individuals can receive IV infusions in a comfortable and safe atmosphere as part of several infusion therapies. With the guidance of a trustworthy health provider, a patient recovering from surgery or undergoing surgery therapy can access a variety of home care infusion services. Professionals can assist patients with all types of infusions, from the first interaction with the client to providing professional home therapy.
To reduce the strain on the primary healthcare services
The market is expected to grow in response to the growing need to shorten inpatient stays. According to the American Hospital Association, there were approximately 36,241,815 hospital admissions in all US hospitals in 2019. This has prompted the development of ways for administering infusion therapy at home or in other healthcare settings, which is expected to boost the market growth. While hospitals have quickly adopted smart infusion pumps with useful features like EHR connection, drug libraries, and medication safety software, most home infusion providers still use classic infusion pumps. However, due to rising demand, there has been a growing trend for equipment upgrades, particularly in developed countries thus, supporting the development of the home infusion therapy market over the forecast period.
Restraints:
Third-Party service providers and low reimbursement policies
The issue of fragmented care may develop in the home infusion setting if the home infusion provider is a third-party company that is not part of the patient's primary care team. Concerns about the patient's limited access to their care team may also cause issues, as eliminating the requirement for patients to visit the clinic for each infusion reduces their interaction with their provider. Other issues that may develop include the patient's potential limited access to emergency services if a negative reaction or adverse event (AE) occurs during the infusion thus, hampering the growth of the market over the projected timeframe.
Opportunities:
Growing Geriatric Population
According to the United Nations, the world's population will grow by one billion people by 2025, with roughly a third of them being 65 or older as life expectancy rises. Middle-class comforts and urbanization are also on the rise, potentially leading to more sedentary lifestyles and chronic illnesses. There is concern that all of this will place a further strain on the global health system's ability to administer and pay for care. As a result, there has been a significant shift in healthcare toward a more patient-centered, community-based approach. Regulations in the healthcare industry have supported the growth of the home infusion therapy market. For instance, healthcare systems in the USA are implementing new guidelines to support home infusion therapies thus, creating a lucrative opportunity for the market players.
Market Segmentation
By product type, the infusion pump segment is anticipated to have the highest share of the home infusion therapy market. It is projected to record a 5.4% CAGR and reach USD 18.2 billion by the end of the analysis period. Infusion pumps have numerous benefits over manual fluid administration, including the ability to give fluids in very small quantities and at precisely programmed rates or automatic intervals. They can be utilized to administer nutrients or pharmaceuticals like insulin or other hormones, antibiotics, chemotherapeutic treatments, and pain relievers. Large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps are among the various types of infusion pumps available.
By infusion type, the continuous segment is estimated to dominate the infusion therapy market. Continuous infusion maintains a constant concentration of microbubbles, lowering the risk of artifacts. If there is a steady-state concentration of contrast, it is also possible to compute myocardial blood flow, as both myocardial blood volume and microbubble velocity can be calculated. Continuous infusion strategies have been found in studies to be the best options for drug administration in cancer patients thus, supporting the growth of the segment.
By application, the anti-infective segment is anticipated to lead the growth of the home infusion therapy market. One of the most regularly prescribed home infusion therapies is anti-infective therapy (antibiotics, antifungals, and antivirals), which can be safely managed at home. Cystic fibrosis, Lyme disease, Osteomyelitis, and other infections that require long-term anti-infective therapy can all be caused by a variety of causes. If not treated properly, each of these clinical disorders can lead to unnecessary hospitalization and/or emergency room visits. These disorders can be treated at home using infusion therapy, which can help avert life-threatening situations thus, boosting the development of the segment.
Players Covered in Home Infusion Therapy market are :
- CVS/Coram
- Option Care Health
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica
- Fresenius Kabi
- ICU Medical Inc.
- B. Braun Melsungen AG
- Baxter
- BD
- Caesarea Medical Electronics
- Smiths Medical
- Terumo Corporation
- JMS Co. Ltd and others major players.
Regional Analysis of Home Infusion Therapy Market:
In North America, particularly in the United States and Canada, the home infusion therapy market is well-established and growing steadily. Factors driving this growth include a large elderly population with chronic conditions, favorable reimbursement policies from Medicare and private insurers, and advanced healthcare infrastructure supporting home-based care. The region also benefits from a robust network of specialty pharmacies and home healthcare providers offering comprehensive infusion services, coupled with stringent regulatory standards ensuring patient safety and quality of care.
In Europe, the home infusion therapy sector is expanding as healthcare systems increasingly prioritize cost-effective care delivery and patient-centered services. Countries like the United Kingdom, Germany, and France lead in adopting home-based infusion therapies, driven by aging populations and a shift towards reducing hospital admissions. Regulatory harmonization across the European Union facilitates cross-border collaboration among healthcare providers and promotes standardization of care practices.
Overall, regional variations in healthcare systems, regulatory environments, economic conditions, and patient preferences shape the development and adoption of home infusion therapy globally. As the industry continues to evolve, stakeholders must navigate these diverse landscapes to capitalize on opportunities and address challenges in delivering quality, accessible care to patients in their homes.
Recent Industry Developments in Home Infusion Therapy Market
- In January 2024, BrightStar Care collaborated with Paragon Healthcare to offer high-quality home infusion services. This strategic collaboration enables Paragon Healthcare to efficiently enhance the delivery of high-quality home infusion services to a broader clientele through BrightStar Care's nurse-led, Joint Commission-accredited care model.
- In January 2023, KORU Medical Systems, Inc. has partnered with a pharmaceutical manufacturer to develop and approve the Freedom Infusion System, which uses a prefilled syringe for subcutaneous immunoglobulin therapy (SCIg). The system includes Freddom60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets for home and alternate care settings.
Global Home Infusion Therapy Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 22.98 Bn. |
Forecast Period 2024-32 CAGR: |
6.62% |
Market Size in 2032: |
USD 40.92 Bn. |
Segments Covered: |
By Type |
|
|
By Infusion Type |
|
||
By Application |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
ā1.1 Research Objectives
ā1.2 Research Methodology
ā1.3 Research Process
ā1.4 Scope and Coverage
āā1.4.1 Market Definition
āā1.4.2 Key Questions Answered
ā1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
ā3.1 By Type
ā3.2 By Infusion Type
ā3.3 By Application
Chapter 4: Market Landscape
ā4.1 Porter's Five Forces Analysis
āā4.1.1 Bargaining Power of Supplier
āā4.1.2 Threat of New Entrants
āā4.1.3 Threat of Substitutes
āā4.1.4 Competitive Rivalry
āā4.1.5 Bargaining Power Among Buyers
ā4.2 Industry Value Chain Analysis
ā4.3 Market Dynamics
āā4.3.1 Drivers
āā4.3.2 Restraints
āā4.3.3 Opportunities
āā4.5.4 Challenges
ā4.4 Pestle Analysis
ā4.5 Technological Roadmap
ā4.6 Regulatory Landscape
ā4.7 SWOT Analysis
ā4.8 Price Trend Analysis
ā4.9 Patent Analysis
ā4.10 Analysis of the Impact of Covid-19
āā4.10.1 Impact on the Overall Market
āā4.10.2 Impact on the Supply Chain
āā4.10.3 Impact on the Key Manufacturers
āā4.10.4 Impact on the Pricing
Chapter 5: Home Infusion Therapy Market by Type
ā5.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā5.2 Home Infusion Therapy Market Overview
ā5.3 IV Cannulas
āā5.3.1 Introduction and Market Overview
āā5.3.2 Historic and Forecasted Market Size (2017-2032F)
āā5.3.3 Key Market Trends, Growth Factors and Opportunities
āā5.3.4 IV Cannulas: Grographic Segmentation
ā5.4 Infusion Pumps
āā5.4.1 Introduction and Market Overview
āā5.4.2 Historic and Forecasted Market Size (2017-2032F)
āā5.4.3 Key Market Trends, Growth Factors and Opportunities
āā5.4.4 Infusion Pumps: Grographic Segmentation
ā5.5 Needleless Connectors
āā5.5.1 Introduction and Market Overview
āā5.5.2 Historic and Forecasted Market Size (2017-2032F)
āā5.5.3 Key Market Trends, Growth Factors and Opportunities
āā5.5.4 Needleless Connectors: Grographic Segmentation
ā5.6 Intravenous Sets
āā5.6.1 Introduction and Market Overview
āā5.6.2 Historic and Forecasted Market Size (2016-2028F)
āā5.6.3 Key Market Trends, Growth Factors and Opportunities
āā5.6.4 Intravenous Sets: Grographic Segmentation
Chapter 6: Home Infusion Therapy Market by Infusion Type
ā6.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā6.2 Home Infusion Therapy Market Overview
ā6.3 Continuous
āā6.3.1 Introduction and Market Overview
āā6.3.2 Historic and Forecasted Market Size (2017-2032F)
āā6.3.3 Key Market Trends, Growth Factors and Opportunities
āā6.3.4 Continuous: Grographic Segmentation
ā6.4 Secondary IV
āā6.4.1 Introduction and Market Overview
āā6.4.2 Historic and Forecasted Market Size (2017-2032F)
āā6.4.3 Key Market Trends, Growth Factors and Opportunities
āā6.4.4 Secondary IV: Grographic Segmentation
ā6.5 IV Push
āā6.5.1 Introduction and Market Overview
āā6.5.2 Historic and Forecasted Market Size (2017-2032F)
āā6.5.3 Key Market Trends, Growth Factors and Opportunities
āā6.5.4 IV Push: Grographic Segmentation
Chapter 7: Home Infusion Therapy Market by Application
ā7.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā7.2 Home Infusion Therapy Market Overview
ā7.3 Anti-Infective
āā7.3.1 Introduction and Market Overview
āā7.3.2 Historic and Forecasted Market Size (2017-2032F)
āā7.3.3 Key Market Trends, Growth Factors and Opportunities
āā7.3.4 Anti-Infective: Grographic Segmentation
ā7.4 Endocrinology
āā7.4.1 Introduction and Market Overview
āā7.4.2 Historic and Forecasted Market Size (2017-2032F)
āā7.4.3 Key Market Trends, Growth Factors and Opportunities
āā7.4.4 Endocrinology: Grographic Segmentation
ā7.5 Enteral Nutrition
āā7.5.1 Introduction and Market Overview
āā7.5.2 Historic and Forecasted Market Size (2017-2032F)
āā7.5.3 Key Market Trends, Growth Factors and Opportunities
āā7.5.4 Enteral Nutrition: Grographic Segmentation
ā7.6 Parenteral Nutrition
āā7.6.1 Introduction and Market Overview
āā7.6.2 Historic and Forecasted Market Size (2017-2032F)
āā7.6.3 Key Market Trends, Growth Factors and Opportunities
āā7.6.4 Parenteral Nutrition: Grographic Segmentation
ā7.7 Others
āā7.7.1 Introduction and Market Overview
āā7.7.2 Historic and Forecasted Market Size (2017-2032F)
āā7.7.3 Key Market Trends, Growth Factors and Opportunities
āā7.7.4 Others: Grographic Segmentation
Chapter 8: Company Profiles and Competitive Analysis
ā8.1 Competitive Landscape
āā8.1.1 Competitive Positioning
āā8.1.2 Home Infusion Therapy Sales and Market Share By Players
āā8.1.3 Industry BCG Matrix
āā8.1.4 Ansoff Matrix
āā8.1.5 Home Infusion Therapy Industry Concentration Ratio (CR5 and HHI)
āā8.1.6 Top 5 Home Infusion Therapy Players Market Share
āā8.1.7 Mergers and Acquisitions
āā8.1.8 Business Strategies By Top Players
ā8.2 CVS/CORAM
āā8.2.1 Company Overview
āā8.2.2 Key Executives
āā8.2.3 Company Snapshot
āā8.2.4 Operating Business Segments
āā8.2.5 Product Portfolio
āā8.2.6 Business Performance
āā8.2.7 Key Strategic Moves and Recent Developments
āā8.2.8 SWOT Analysis
ā8.3 OPTION CARE HEALTH
ā8.4 BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM)
ā8.5 PHARMERICA
ā8.6 FRESENIUS KABI
ā8.7 ICU MEDICAL INC.
ā8.8 B. BRAUN MELSUNGEN AG
ā8.9 BAXTER
ā8.10 BD
ā8.11 CAESAREA MEDICAL ELECTRONICS
ā8.12 SMITHS MEDICAL
ā8.13 TERUMO CORPORATION
ā8.14 JMS CO. LTD.
ā8.15 OTHERS MAJOR PLAYERS
Chapter 9: Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā9.1 Market Overview
ā9.2 Historic and Forecasted Market Size By Type
āā9.2.1 IV Cannulas
āā9.2.2 Infusion Pumps
āā9.2.3 Needleless Connectors
āā9.2.4 Intravenous Sets
ā9.3 Historic and Forecasted Market Size By Infusion Type
āā9.3.1 Continuous
āā9.3.2 Secondary IV
āā9.3.3 IV Push
ā9.4 Historic and Forecasted Market Size By Application
āā9.4.1 Anti-Infective
āā9.4.2 Endocrinology
āā9.4.3 Enteral Nutrition
āā9.4.4 Parenteral Nutrition
āā9.4.5 Others
Chapter 10: North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā10.1 Key Market Trends, Growth Factors and Opportunities
ā10.2 Impact of Covid-19
ā10.3 Key Players
ā10.4 Key Market Trends, Growth Factors and Opportunities
ā10.4 Historic and Forecasted Market Size By Type
āā10.4.1 IV Cannulas
āā10.4.2 Infusion Pumps
āā10.4.3 Needleless Connectors
āā10.4.4 Intravenous Sets
ā10.5 Historic and Forecasted Market Size By Infusion Type
āā10.5.1 Continuous
āā10.5.2 Secondary IV
āā10.5.3 IV Push
ā10.6 Historic and Forecasted Market Size By Application
āā10.6.1 Anti-Infective
āā10.6.2 Endocrinology
āā10.6.3 Enteral Nutrition
āā10.6.4 Parenteral Nutrition
āā10.6.5 Others
ā10.7 Historic and Forecast Market Size by Country
āā10.7.1 U.S.
āā10.7.2 Canada
āā10.7.3 Mexico
Chapter 11: Europe Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā11.1 Key Market Trends, Growth Factors and Opportunities
ā11.2 Impact of Covid-19
ā11.3 Key Players
ā11.4 Key Market Trends, Growth Factors and Opportunities
ā11.4 Historic and Forecasted Market Size By Type
āā11.4.1 IV Cannulas
āā11.4.2 Infusion Pumps
āā11.4.3 Needleless Connectors
āā11.4.4 Intravenous Sets
ā11.5 Historic and Forecasted Market Size By Infusion Type
āā11.5.1 Continuous
āā11.5.2 Secondary IV
āā11.5.3 IV Push
ā11.6 Historic and Forecasted Market Size By Application
āā11.6.1 Anti-Infective
āā11.6.2 Endocrinology
āā11.6.3 Enteral Nutrition
āā11.6.4 Parenteral Nutrition
āā11.6.5 Others
ā11.7 Historic and Forecast Market Size by Country
āā11.7.1 Germany
āā11.7.2 U.K.
āā11.7.3 France
āā11.7.4 Italy
āā11.7.5 Russia
āā11.7.6 Spain
āā11.7.7 Rest of Europe
Chapter 12: Asia-Pacific Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā12.1 Key Market Trends, Growth Factors and Opportunities
ā12.2 Impact of Covid-19
ā12.3 Key Players
ā12.4 Key Market Trends, Growth Factors and Opportunities
ā12.4 Historic and Forecasted Market Size By Type
āā12.4.1 IV Cannulas
āā12.4.2 Infusion Pumps
āā12.4.3 Needleless Connectors
āā12.4.4 Intravenous Sets
ā12.5 Historic and Forecasted Market Size By Infusion Type
āā12.5.1 Continuous
āā12.5.2 Secondary IV
āā12.5.3 IV Push
ā12.6 Historic and Forecasted Market Size By Application
āā12.6.1 Anti-Infective
āā12.6.2 Endocrinology
āā12.6.3 Enteral Nutrition
āā12.6.4 Parenteral Nutrition
āā12.6.5 Others
ā12.7 Historic and Forecast Market Size by Country
āā12.7.1 China
āā12.7.2 India
āā12.7.3 Japan
āā12.7.4 Singapore
āā12.7.5 Australia
āā12.7.6 New Zealand
āā12.7.7 Rest of APAC
Chapter 13: Middle East & Africa Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā13.1 Key Market Trends, Growth Factors and Opportunities
ā13.2 Impact of Covid-19
ā13.3 Key Players
ā13.4 Key Market Trends, Growth Factors and Opportunities
ā13.4 Historic and Forecasted Market Size By Type
āā13.4.1 IV Cannulas
āā13.4.2 Infusion Pumps
āā13.4.3 Needleless Connectors
āā13.4.4 Intravenous Sets
ā13.5 Historic and Forecasted Market Size By Infusion Type
āā13.5.1 Continuous
āā13.5.2 Secondary IV
āā13.5.3 IV Push
ā13.6 Historic and Forecasted Market Size By Application
āā13.6.1 Anti-Infective
āā13.6.2 Endocrinology
āā13.6.3 Enteral Nutrition
āā13.6.4 Parenteral Nutrition
āā13.6.5 Others
ā13.7 Historic and Forecast Market Size by Country
āā13.7.1 Turkey
āā13.7.2 Saudi Arabia
āā13.7.3 Iran
āā13.7.4 UAE
āā13.7.5 Africa
āā13.7.6 Rest of MEA
Chapter 14: South America Home Infusion Therapy Market Analysis, Insights and Forecast,2017-2032
ā14.1 Key Market Trends, Growth Factors and Opportunities
ā14.2 Impact of Covid-19
ā14.3 Key Players
ā14.4 Key Market Trends, Growth Factors and Opportunities
ā14.4 Historic and Forecasted Market Size By Type
āā14.4.1 IV Cannulas
āā14.4.2 Infusion Pumps
āā14.4.3 Needleless Connectors
āā14.4.4 Intravenous Sets
ā14.5 Historic and Forecasted Market Size By Infusion Type
āā14.5.1 Continuous
āā14.5.2 Secondary IV
āā14.5.3 IV Push
ā14.6 Historic and Forecasted Market Size By Application
āā14.6.1 Anti-Infective
āā14.6.2 Endocrinology
āā14.6.3 Enteral Nutrition
āā14.6.4 Parenteral Nutrition
āā14.6.5 Others
ā14.7 Historic and Forecast Market Size by Country
āā14.7.1 Brazil
āā14.7.2 Argentina
āā14.7.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Global Home Infusion Therapy Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 22.98 Bn. |
Forecast Period 2024-32 CAGR: |
6.62% |
Market Size in 2032: |
USD 40.92 Bn. |
Segments Covered: |
By Type |
|
|
By Infusion Type |
|
||
By Application |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Home Infusion Therapy Market research report is 2024-2032.
CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd., and Other Major Players.
Home Infusion Therapy Market is segmented into Type, Infusion Type, Application and region. By Type, the market is categorized into IV Cannulas, Infusion Pumps, Needleless Connectors, and Intravenous Sets. By Infusion Type, the market is categorized into Continuous, Secondary IV, and IV Push. By Application, the market is categorized into Anti-Infective, Endocrinology, Enteral Nutrition, Parenteral Nutrition, Others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
The intravenous or subcutaneous injection of medications or biologicals to a patient at home is termed home infusion therapy. The medicine (antivirals, immune globulin), equipment (pump), and supplies (tubing and catheters) are required for home infusion.
The Global Home Infusion Therapy Market size is expected to grow from USD 22.98 billion in 2023 to USD 40.92 billion by 2032, at a CAGR of 6.62% during the forecast period (2024-2032).